BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

313 related articles for article (PubMed ID: 12393552)

  • 1. Differential signaling via surface IgM is associated with VH gene mutational status and CD38 expression in chronic lymphocytic leukemia.
    Lanham S; Hamblin T; Oscier D; Ibbotson R; Stevenson F; Packham G
    Blood; 2003 Feb; 101(3):1087-93. PubMed ID: 12393552
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of ZAP-70 is associated with increased B-cell receptor signaling in chronic lymphocytic leukemia.
    Chen L; Widhopf G; Huynh L; Rassenti L; Rai KR; Weiss A; Kipps TJ
    Blood; 2002 Dec; 100(13):4609-14. PubMed ID: 12393534
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structural and functional features of the B-cell receptor in IgG-positive chronic lymphocytic leukemia.
    Potter KN; Mockridge CI; Neville L; Wheatley I; Schenk M; Orchard J; Duncombe AS; Packham G; Stevenson FK
    Clin Cancer Res; 2006 Mar; 12(6):1672-9. PubMed ID: 16551848
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ZAP-70 expression identifies a chronic lymphocytic leukemia subtype with unmutated immunoglobulin genes, inferior clinical outcome, and distinct gene expression profile.
    Wiestner A; Rosenwald A; Barry TS; Wright G; Davis RE; Henrickson SE; Zhao H; Ibbotson RE; Orchard JA; Davis Z; Stetler-Stevenson M; Raffeld M; Arthur DC; Marti GE; Wilson WH; Hamblin TJ; Oscier DG; Staudt LM
    Blood; 2003 Jun; 101(12):4944-51. PubMed ID: 12595313
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sustained signaling through the B-cell receptor induces Mcl-1 and promotes survival of chronic lymphocytic leukemia B cells.
    Petlickovski A; Laurenti L; Li X; Marietti S; Chiusolo P; Sica S; Leone G; Efremov DG
    Blood; 2005 Jun; 105(12):4820-7. PubMed ID: 15728130
    [TBL] [Abstract][Full Text] [Related]  

  • 6. V(H) mutation status, CD38 expression level, genomic aberrations, and survival in chronic lymphocytic leukemia.
    Kröber A; Seiler T; Benner A; Bullinger L; Brückle E; Lichter P; Döhner H; Stilgenbauer S
    Blood; 2002 Aug; 100(4):1410-6. PubMed ID: 12149225
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Laboratory, morphologic, and immunophenotypic correlates of surface immunoglobulin heavy chain isotype expression in B-cell chronic lymphocytic leukemia.
    Shen PU; Fuller SG; Rezuke WN; Sherburne BJ; DiGiuseppe JA
    Am J Clin Pathol; 2001 Dec; 116(6):905-12. PubMed ID: 11764081
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ZAP-70 directly enhances IgM signaling in chronic lymphocytic leukemia.
    Chen L; Apgar J; Huynh L; Dicker F; Giago-McGahan T; Rassenti L; Weiss A; Kipps TJ
    Blood; 2005 Mar; 105(5):2036-41. PubMed ID: 15514014
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reversible anergy of sIgM-mediated signaling in the two subsets of CLL defined by VH-gene mutational status.
    Mockridge CI; Potter KN; Wheatley I; Neville LA; Packham G; Stevenson FK
    Blood; 2007 May; 109(10):4424-31. PubMed ID: 17255355
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HS1 protein is differentially expressed in chronic lymphocytic leukemia patient subsets with good or poor prognoses.
    Scielzo C; Ghia P; Conti A; Bachi A; Guida G; Geuna M; Alessio M; Caligaris-Cappio F
    J Clin Invest; 2005 Jun; 115(6):1644-50. PubMed ID: 15931393
    [TBL] [Abstract][Full Text] [Related]  

  • 11. BCR ligation induced by IgM stimulation results in gene expression and functional changes only in IgV H unmutated chronic lymphocytic leukemia (CLL) cells.
    Guarini A; Chiaretti S; Tavolaro S; Maggio R; Peragine N; Citarella F; Ricciardi MR; Santangelo S; Marinelli M; De Propris MS; Messina M; Mauro FR; Del Giudice I; Foà R
    Blood; 2008 Aug; 112(3):782-92. PubMed ID: 18487510
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stereotyped subset #1 chronic lymphocytic leukemia: a direct link between B-cell receptor structure, function, and patients' prognosis.
    Del Giudice I; Chiaretti S; Santangelo S; Tavolaro S; Peragine N; Marinelli M; Ilari C; Raponi S; Messina M; Nanni M; Mauro FR; Piciocchi A; Bontempi K; Rossi D; Gaidano G; Guarini A; Foà R
    Am J Hematol; 2014 Jan; 89(1):74-82. PubMed ID: 24030933
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ZAP-70 expression as a surrogate for immunoglobulin-variable-region mutations in chronic lymphocytic leukemia.
    Crespo M; Bosch F; Villamor N; Bellosillo B; Colomer D; Rozman M; Marcé S; López-Guillermo A; Campo E; Montserrat E
    N Engl J Med; 2003 May; 348(18):1764-75. PubMed ID: 12724482
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The pattern of CD38 expression defines a distinct subset of chronic lymphocytic leukemia (CLL) patients at risk of disease progression.
    Ghia P; Guida G; Stella S; Gottardi D; Geuna M; Strola G; Scielzo C; Caligaris-Cappio F
    Blood; 2003 Feb; 101(4):1262-9. PubMed ID: 12406914
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Apoptosis or plasma cell differentiation of CD38-positive B-chronic lymphocytic leukemia cells induced by cross-linking of surface IgM or IgD.
    Zupo S; Massara R; Dono M; Rossi E; Malavasi F; Cosulich ME; Ferrarini M
    Blood; 2000 Feb; 95(4):1199-206. PubMed ID: 10666191
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD38 expression and immunoglobulin variable region mutations are independent prognostic variables in chronic lymphocytic leukemia, but CD38 expression may vary during the course of the disease.
    Hamblin TJ; Orchard JA; Ibbotson RE; Davis Z; Thomas PW; Stevenson FK; Oscier DG
    Blood; 2002 Feb; 99(3):1023-9. PubMed ID: 11807008
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD38 expression distinguishes two groups of B-cell chronic lymphocytic leukemias with different responses to anti-IgM antibodies and propensity to apoptosis.
    Zupo S; Isnardi L; Megna M; Massara R; Malavasi F; Dono M; Cosulich E; Ferrarini M
    Blood; 1996 Aug; 88(4):1365-74. PubMed ID: 8695855
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of ZAP-70 protein correlates with disease stage in chronic lymphocytic leukemia and is associated with, but not generally restricted to, non-mutated Ig VH status.
    Kim SZ; Chow KU; Kukoc-Zivojnov N; Boehrer S; Brieger A; Steimle-Grauer SA; Harder L; Hoelzer D; Mitrou PS; Weidmann E
    Leuk Lymphoma; 2004 Oct; 45(10):2037-45. PubMed ID: 15370248
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Surface antigen expression and correlation with variable heavy-chain gene mutation status in chronic lymphocytic leukemia.
    Vilpo J; Tobin G; Hulkkonen J; Hurme M; Thunberg U; Sundström C; Vilpo L; Rosenquist R
    Eur J Haematol; 2003 Jan; 70(1):53-9. PubMed ID: 12631259
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chronic lymphocytic leukemia patients with highly stable and indolent disease show distinctive phenotypic and genotypic features.
    Guarini A; Gaidano G; Mauro FR; Capello D; Mancini F; De Propris MS; Mancini M; Orsini E; Gentile M; Breccia M; Cuneo A; Castoldi G; Foa R
    Blood; 2003 Aug; 102(3):1035-41. PubMed ID: 12676780
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.